ArticleNature communications2015

Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy.

Ioannis Karakikes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.